» Articles » PMID: 12408863

Drosophila Enhancer of Zeste/ESC Complexes Have a Histone H3 Methyltransferase Activity That Marks Chromosomal Polycomb Sites

Overview
Journal Cell
Publisher Cell Press
Specialty Cell Biology
Date 2002 Nov 1
PMID 12408863
Citations 723
Authors
Affiliations
Soon will be listed here.
Abstract

Enhancer of Zeste is a Polycomb Group protein essential for the establishment and maintenance of repression of homeotic and other genes. In the early embryo it is found in a complex that includes ESC and is recruited to Polycomb Response Elements. We show that this complex contains a methyltransferase activity that methylates lysine 9 and lysine 27 of histone H3, but the activity is lost when the E(Z) SET domain is mutated. The lysine 9 position is trimethylated and this mark is closely associated with Polycomb binding sites on polytene chromosomes but is also found in centric heterochromatin, chromosome 4, and telomeric sites. Histone H3 methylated in vitro by the E(Z)/ESC complex binds specifically to Polycomb protein.

Citing Articles

PRC2 promotes canalisation during endodermal differentiation.

Holzenspies J, Sengupta D, Bickmore W, Brickman J, Illingworth R PLoS Genet. 2025; 21(1):e1011584.

PMID: 39883738 PMC: 11813121. DOI: 10.1371/journal.pgen.1011584.


Targeting EZH2 in Cancer: Mechanisms, Pathways, and Therapeutic Potential.

Gilardini Montani M, Benedetti R, Cirone M Molecules. 2025; 29(24.

PMID: 39769907 PMC: 11678268. DOI: 10.3390/molecules29245817.


Evaluation of circANKLE2 & circL3MBTL4 -RNAs Expression in Fertile and Infertile Men.

El-Gamal R, Zalata A, Mazroa S, Comhaire F, Gamal A, Shaker O Biochem Genet. 2024; .

PMID: 39580773 DOI: 10.1007/s10528-024-10963-7.


Epigenetic regulation by polycomb repressive complex 1 promotes cerebral cavernous malformations.

Pham V, Rodel C, Valentino M, Malinverno M, Paolini A, Munch J EMBO Mol Med. 2024; 16(11):2827-2855.

PMID: 39402138 PMC: 11555420. DOI: 10.1038/s44321-024-00152-9.


miR-4448/Girdin/Akt/AMPK axis inhibits EZH2-mediated EMT and tumorigenesis in small-cell lung cancer.

Koyama N, Ishikawa Y, Ohta H, Aoki T, Kyoyama H, Aoshiba K Cancer Med. 2024; 13(19):e70093.

PMID: 39400978 PMC: 11476246. DOI: 10.1002/cam4.70093.